nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—migraine—Prednisone—psoriasis	0.192	0.508	CpDpCtD
Acetaminophen—osteoarthritis—Prednisone—psoriasis	0.185	0.492	CpDpCtD
Acetaminophen—UGT1A6—Mycophenolic acid—psoriasis	0.0996	0.202	CbGbCtD
Acetaminophen—UGT1A10—Mycophenolate mofetil—psoriasis	0.0644	0.131	CbGbCtD
Acetaminophen—UGT1A6—Mycophenolate mofetil—psoriasis	0.0556	0.113	CbGbCtD
Acetaminophen—UGT1A9—Mycophenolic acid—psoriasis	0.029	0.0589	CbGbCtD
Acetaminophen—UGT1A1—Mycophenolic acid—psoriasis	0.0237	0.0482	CbGbCtD
Acetaminophen—CYP1A1—Clobetasol propionate—psoriasis	0.0223	0.0453	CbGbCtD
Acetaminophen—UGT1A9—Mycophenolate mofetil—psoriasis	0.0162	0.0329	CbGbCtD
Acetaminophen—CYP2A6—Methoxsalen—psoriasis	0.0137	0.0278	CbGbCtD
Acetaminophen—UGT1A1—Mycophenolate mofetil—psoriasis	0.0133	0.0269	CbGbCtD
Acetaminophen—CYP1A1—Methoxsalen—psoriasis	0.0117	0.0238	CbGbCtD
Acetaminophen—CYP2C8—Tazarotene—psoriasis	0.0105	0.0213	CbGbCtD
Acetaminophen—CYP1A2—Clobetasol propionate—psoriasis	0.00998	0.0202	CbGbCtD
Acetaminophen—PTGS2—Triamcinolone—psoriasis	0.00798	0.0162	CbGbCtD
Acetaminophen—CYP1A1—Cholecalciferol—psoriasis	0.00777	0.0158	CbGbCtD
Acetaminophen—PTGS2—Betamethasone—psoriasis	0.00684	0.0139	CbGbCtD
Acetaminophen—CYP2A6—Prednisolone—psoriasis	0.00668	0.0135	CbGbCtD
Acetaminophen—CYP1A2—Methoxsalen—psoriasis	0.00524	0.0106	CbGbCtD
Acetaminophen—CYP2D6—Hydroxyurea—psoriasis	0.00472	0.00957	CbGbCtD
Acetaminophen—CYP2C8—Cholecalciferol—psoriasis	0.00448	0.00909	CbGbCtD
Acetaminophen—SLC22A6—Cyclosporine—psoriasis	0.00448	0.00908	CbGbCtD
Acetaminophen—PTGS2—Dexamethasone—psoriasis	0.00398	0.00807	CbGbCtD
Acetaminophen—CYP2A6—Dexamethasone—psoriasis	0.00394	0.00798	CbGbCtD
Acetaminophen—CYP2C8—Mycophenolate mofetil—psoriasis	0.00389	0.00788	CbGbCtD
Acetaminophen—CYP3A4—Calcitriol—psoriasis	0.00353	0.00716	CbGbCtD
Acetaminophen—CYP1A1—Dexamethasone—psoriasis	0.00336	0.00682	CbGbCtD
Acetaminophen—CYP2C9—Cholecalciferol—psoriasis	0.00313	0.00634	CbGbCtD
Acetaminophen—CYP2C8—Hydrocortisone—psoriasis	0.00312	0.00633	CbGbCtD
Acetaminophen—CYP2C8—Cyclosporine—psoriasis	0.00295	0.00598	CbGbCtD
Acetaminophen—CYP2D6—Cholecalciferol—psoriasis	0.00286	0.0058	CbGbCtD
Acetaminophen—CYP3A4—Methoxsalen—psoriasis	0.00275	0.00557	CbGbCtD
Acetaminophen—ABCB1—Mycophenolate mofetil—psoriasis	0.00263	0.00534	CbGbCtD
Acetaminophen—CYP2E1—Dexamethasone—psoriasis	0.0026	0.00527	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—psoriasis	0.00237	0.0048	CbGbCtD
Acetaminophen—ABCB1—Betamethasone—psoriasis	0.00226	0.00458	CbGbCtD
Acetaminophen—ABCB1—Prednisolone—psoriasis	0.00223	0.00452	CbGbCtD
Acetaminophen—ABCB1—Hydrocortisone—psoriasis	0.00211	0.00428	CbGbCtD
Acetaminophen—ABCB1—Prednisone—psoriasis	0.0021	0.00427	CbGbCtD
Acetaminophen—CYP2C9—Cyclosporine—psoriasis	0.00206	0.00417	CbGbCtD
Acetaminophen—ABCB1—Cyclosporine—psoriasis	0.00199	0.00404	CbGbCtD
Acetaminophen—CYP2C8—Dexamethasone—psoriasis	0.00194	0.00393	CbGbCtD
Acetaminophen—CYP2D6—Cyclosporine—psoriasis	0.00188	0.00381	CbGbCtD
Acetaminophen—CYP3A4—Cholecalciferol—psoriasis	0.00182	0.00369	CbGbCtD
Acetaminophen—CYP3A4—Mycophenolate mofetil—psoriasis	0.00158	0.0032	CbGbCtD
Acetaminophen—CYP3A4—Triamcinolone—psoriasis	0.00158	0.0032	CbGbCtD
Acetaminophen—CYP2C9—Dexamethasone—psoriasis	0.00135	0.00274	CbGbCtD
Acetaminophen—CYP3A4—Betamethasone—psoriasis	0.00135	0.00274	CbGbCtD
Acetaminophen—CYP3A4—Prednisolone—psoriasis	0.00133	0.00271	CbGbCtD
Acetaminophen—ABCB1—Dexamethasone—psoriasis	0.00131	0.00266	CbGbCtD
Acetaminophen—CYP3A4—Hydrocortisone—psoriasis	0.00127	0.00257	CbGbCtD
Acetaminophen—CYP3A4—Prednisone—psoriasis	0.00126	0.00256	CbGbCtD
Acetaminophen—CYP2D6—Dexamethasone—psoriasis	0.00124	0.00251	CbGbCtD
Acetaminophen—CYP3A4—Cyclosporine—psoriasis	0.00119	0.00242	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—psoriasis	0.00106	0.00214	CbGbCtD
Acetaminophen—CYP3A4—Dexamethasone—psoriasis	0.000787	0.0016	CbGbCtD
Acetaminophen—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000333	0.157	CbGdCrCtD
Acetaminophen—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000267	0.126	CbGdCrCtD
Acetaminophen—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000259	0.122	CbGdCrCtD
Acetaminophen—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000201	0.0949	CbGdCrCtD
Acetaminophen—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000161	0.076	CbGdCrCtD
Acetaminophen—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000161	0.076	CbGdCrCtD
Acetaminophen—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000156	0.0738	CbGdCrCtD
Acetaminophen—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000122	0.0574	CbGdCrCtD
Acetaminophen—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000122	0.0574	CbGdCrCtD
Acetaminophen—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000119	0.0561	CbGdCrCtD
Acetaminophen—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	7.33e-05	0.0346	CbGdCrCtD
Acetaminophen—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	7.33e-05	0.0346	CbGdCrCtD
Acetaminophen—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	7.17e-05	0.0338	CbGdCrCtD
Acetaminophen—Constipation—Mycophenolate mofetil—psoriasis	5.02e-05	0.000557	CcSEcCtD
Acetaminophen—Sweating—Methotrexate—psoriasis	5e-05	0.000555	CcSEcCtD
Acetaminophen—Hypotension—Hydrocortisone—psoriasis	5e-05	0.000554	CcSEcCtD
Acetaminophen—SULT1E1—Metabolism—CARM1—psoriasis	4.97e-05	0.00132	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IL12B—psoriasis	4.97e-05	0.00132	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Cyclosporine—psoriasis	4.96e-05	0.00055	CcSEcCtD
Acetaminophen—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	4.96e-05	0.00131	CbGpPWpGaD
Acetaminophen—Shock—Triamcinolone—psoriasis	4.96e-05	0.00055	CcSEcCtD
Acetaminophen—Insomnia—Prednisolone—psoriasis	4.95e-05	0.000549	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Methotrexate—psoriasis	4.93e-05	0.000547	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Cyclosporine—psoriasis	4.92e-05	0.000546	CcSEcCtD
Acetaminophen—Dizziness—Mycophenolic acid—psoriasis	4.92e-05	0.000546	CcSEcCtD
Acetaminophen—PTGS2—Overview of nanoparticle effects—IL6—psoriasis	4.92e-05	0.0013	CbGpPWpGaD
Acetaminophen—Tachycardia—Triamcinolone—psoriasis	4.92e-05	0.000545	CcSEcCtD
Acetaminophen—Mental disorder—Prednisone—psoriasis	4.91e-05	0.000544	CcSEcCtD
Acetaminophen—Erythema—Prednisone—psoriasis	4.88e-05	0.000541	CcSEcCtD
Acetaminophen—Malnutrition—Prednisone—psoriasis	4.88e-05	0.000541	CcSEcCtD
Acetaminophen—Hyperhidrosis—Triamcinolone—psoriasis	4.87e-05	0.00054	CcSEcCtD
Acetaminophen—Agranulocytosis—Methotrexate—psoriasis	4.87e-05	0.00054	CcSEcCtD
Acetaminophen—Convulsion—Betamethasone—psoriasis	4.85e-05	0.000538	CcSEcCtD
Acetaminophen—Convulsion—Dexamethasone—psoriasis	4.85e-05	0.000538	CcSEcCtD
Acetaminophen—ABCB1—Allograft Rejection—HLA-E—psoriasis	4.85e-05	0.00129	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.84e-05	0.000537	CcSEcCtD
Acetaminophen—Insomnia—Hydrocortisone—psoriasis	4.84e-05	0.000537	CcSEcCtD
Acetaminophen—Hypertension—Betamethasone—psoriasis	4.84e-05	0.000536	CcSEcCtD
Acetaminophen—Hypertension—Dexamethasone—psoriasis	4.84e-05	0.000536	CcSEcCtD
Acetaminophen—CYP1A1—Oxidative Stress—NFKB1—psoriasis	4.83e-05	0.00128	CbGpPWpGaD
Acetaminophen—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.8e-05	0.000533	CcSEcCtD
Acetaminophen—CNR1—G alpha (i) signalling events—CXCL8—psoriasis	4.8e-05	0.00127	CbGpPWpGaD
Acetaminophen—Urticaria—Cyclosporine—psoriasis	4.78e-05	0.00053	CcSEcCtD
Acetaminophen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.77e-05	0.00127	CbGpPWpGaD
Acetaminophen—Abdominal pain—Cyclosporine—psoriasis	4.76e-05	0.000528	CcSEcCtD
Acetaminophen—Body temperature increased—Cyclosporine—psoriasis	4.76e-05	0.000528	CcSEcCtD
Acetaminophen—Anxiety—Betamethasone—psoriasis	4.75e-05	0.000527	CcSEcCtD
Acetaminophen—Anxiety—Dexamethasone—psoriasis	4.75e-05	0.000527	CcSEcCtD
Acetaminophen—CYP1A2—Tryptophan metabolism—CAT—psoriasis	4.73e-05	0.00125	CbGpPWpGaD
Acetaminophen—Vomiting—Mycophenolic acid—psoriasis	4.73e-05	0.000525	CcSEcCtD
Acetaminophen—Discomfort—Dexamethasone—psoriasis	4.71e-05	0.000522	CcSEcCtD
Acetaminophen—Discomfort—Betamethasone—psoriasis	4.71e-05	0.000522	CcSEcCtD
Acetaminophen—Dyspepsia—Hydrocortisone—psoriasis	4.71e-05	0.000522	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—psoriasis	4.71e-05	0.000522	CcSEcCtD
Acetaminophen—Rash—Mycophenolic acid—psoriasis	4.69e-05	0.00052	CcSEcCtD
Acetaminophen—Dermatitis—Mycophenolic acid—psoriasis	4.69e-05	0.00052	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—psoriasis	4.68e-05	0.000519	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—psoriasis	4.68e-05	0.000519	CcSEcCtD
Acetaminophen—Urticaria—Mycophenolate mofetil—psoriasis	4.67e-05	0.000517	CcSEcCtD
Acetaminophen—Headache—Mycophenolic acid—psoriasis	4.66e-05	0.000517	CcSEcCtD
Acetaminophen—Decreased appetite—Hydrocortisone—psoriasis	4.65e-05	0.000516	CcSEcCtD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.64e-05	0.00123	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.64e-05	0.00123	CbGpPWpGaD
Acetaminophen—Abdominal pain—Mycophenolate mofetil—psoriasis	4.64e-05	0.000515	CcSEcCtD
Acetaminophen—Body temperature increased—Mycophenolate mofetil—psoriasis	4.64e-05	0.000515	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—psoriasis	4.62e-05	0.000513	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.62e-05	0.000512	CcSEcCtD
Acetaminophen—Fatigue—Hydrocortisone—psoriasis	4.61e-05	0.000512	CcSEcCtD
Acetaminophen—Vision blurred—Prednisone—psoriasis	4.6e-05	0.00051	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—psoriasis	4.59e-05	0.000509	CcSEcCtD
Acetaminophen—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	4.57e-05	0.00121	CbGpPWpGaD
Acetaminophen—Oedema—Betamethasone—psoriasis	4.57e-05	0.000507	CcSEcCtD
Acetaminophen—Anaphylactic shock—Dexamethasone—psoriasis	4.57e-05	0.000507	CcSEcCtD
Acetaminophen—Anaphylactic shock—Betamethasone—psoriasis	4.57e-05	0.000507	CcSEcCtD
Acetaminophen—Oedema—Dexamethasone—psoriasis	4.57e-05	0.000507	CcSEcCtD
Acetaminophen—Insomnia—Triamcinolone—psoriasis	4.56e-05	0.000505	CcSEcCtD
Acetaminophen—Ill-defined disorder—Prednisone—psoriasis	4.53e-05	0.000502	CcSEcCtD
Acetaminophen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	4.52e-05	0.0012	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Prednisolone—psoriasis	4.51e-05	0.000501	CcSEcCtD
Acetaminophen—Anaemia—Prednisone—psoriasis	4.51e-05	0.0005	CcSEcCtD
Acetaminophen—Shock—Dexamethasone—psoriasis	4.5e-05	0.000499	CcSEcCtD
Acetaminophen—Shock—Betamethasone—psoriasis	4.5e-05	0.000499	CcSEcCtD
Acetaminophen—Dyspnoea—Triamcinolone—psoriasis	4.49e-05	0.000498	CcSEcCtD
Acetaminophen—Nervous system disorder—Dexamethasone—psoriasis	4.48e-05	0.000497	CcSEcCtD
Acetaminophen—Nervous system disorder—Betamethasone—psoriasis	4.48e-05	0.000497	CcSEcCtD
Acetaminophen—Agitation—Prednisone—psoriasis	4.48e-05	0.000497	CcSEcCtD
Acetaminophen—Thrombocytopenia—Dexamethasone—psoriasis	4.48e-05	0.000496	CcSEcCtD
Acetaminophen—Thrombocytopenia—Betamethasone—psoriasis	4.48e-05	0.000496	CcSEcCtD
Acetaminophen—Tachycardia—Betamethasone—psoriasis	4.46e-05	0.000495	CcSEcCtD
Acetaminophen—Tachycardia—Dexamethasone—psoriasis	4.46e-05	0.000495	CcSEcCtD
Acetaminophen—Angioedema—Prednisone—psoriasis	4.46e-05	0.000494	CcSEcCtD
Acetaminophen—Hypersensitivity—Cyclosporine—psoriasis	4.44e-05	0.000492	CcSEcCtD
Acetaminophen—Dyspepsia—Triamcinolone—psoriasis	4.43e-05	0.000492	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—psoriasis	4.43e-05	0.000491	CcSEcCtD
Acetaminophen—Nausea—Mycophenolic acid—psoriasis	4.42e-05	0.00049	CcSEcCtD
Acetaminophen—Hyperhidrosis—Betamethasone—psoriasis	4.42e-05	0.00049	CcSEcCtD
Acetaminophen—Hyperhidrosis—Dexamethasone—psoriasis	4.42e-05	0.00049	CcSEcCtD
Acetaminophen—Feeling abnormal—Hydrocortisone—psoriasis	4.41e-05	0.000489	CcSEcCtD
Acetaminophen—Malaise—Prednisone—psoriasis	4.4e-05	0.000488	CcSEcCtD
Acetaminophen—SULT1A1—Metabolism—CARM1—psoriasis	4.38e-05	0.00116	CbGpPWpGaD
Acetaminophen—Eye disorder—Methotrexate—psoriasis	4.38e-05	0.000485	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Hydrocortisone—psoriasis	4.37e-05	0.000485	CcSEcCtD
Acetaminophen—Anorexia—Dexamethasone—psoriasis	4.36e-05	0.000483	CcSEcCtD
Acetaminophen—Anorexia—Betamethasone—psoriasis	4.36e-05	0.000483	CcSEcCtD
Acetaminophen—UGT1A9—PPARA activates gene expression—PPARG—psoriasis	4.35e-05	0.00115	CbGpPWpGaD
Acetaminophen—Urticaria—Prednisolone—psoriasis	4.35e-05	0.000483	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—psoriasis	4.35e-05	0.000482	CcSEcCtD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—psoriasis	4.34e-05	0.00115	CbGpPWpGaD
Acetaminophen—Fatigue—Triamcinolone—psoriasis	4.34e-05	0.000482	CcSEcCtD
Acetaminophen—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.33e-05	0.00048	CcSEcCtD
Acetaminophen—Asthenia—Cyclosporine—psoriasis	4.32e-05	0.000479	CcSEcCtD
Acetaminophen—Hypotension—Dexamethasone—psoriasis	4.27e-05	0.000474	CcSEcCtD
Acetaminophen—Hypotension—Betamethasone—psoriasis	4.27e-05	0.000474	CcSEcCtD
Acetaminophen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	4.26e-05	0.00113	CbGpPWpGaD
Acetaminophen—Pruritus—Cyclosporine—psoriasis	4.26e-05	0.000472	CcSEcCtD
Acetaminophen—Urticaria—Hydrocortisone—psoriasis	4.25e-05	0.000471	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—psoriasis	4.25e-05	0.000471	CcSEcCtD
Acetaminophen—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.23e-05	0.00112	CbGpPWpGaD
Acetaminophen—Immune system disorder—Methotrexate—psoriasis	4.23e-05	0.000469	CcSEcCtD
Acetaminophen—Body temperature increased—Hydrocortisone—psoriasis	4.23e-05	0.000469	CcSEcCtD
Acetaminophen—Abdominal pain—Hydrocortisone—psoriasis	4.23e-05	0.000469	CcSEcCtD
Acetaminophen—Convulsion—Prednisone—psoriasis	4.23e-05	0.000469	CcSEcCtD
Acetaminophen—Mediastinal disorder—Methotrexate—psoriasis	4.22e-05	0.000468	CcSEcCtD
Acetaminophen—Asthenia—Mycophenolate mofetil—psoriasis	4.21e-05	0.000467	CcSEcCtD
Acetaminophen—Hypertension—Prednisone—psoriasis	4.21e-05	0.000467	CcSEcCtD
Acetaminophen—Chills—Methotrexate—psoriasis	4.2e-05	0.000466	CcSEcCtD
Acetaminophen—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.17e-05	0.00111	CbGpPWpGaD
Acetaminophen—Pruritus—Mycophenolate mofetil—psoriasis	4.15e-05	0.000461	CcSEcCtD
Acetaminophen—Feeling abnormal—Triamcinolone—psoriasis	4.15e-05	0.00046	CcSEcCtD
Acetaminophen—Anxiety—Prednisone—psoriasis	4.14e-05	0.000459	CcSEcCtD
Acetaminophen—Insomnia—Betamethasone—psoriasis	4.13e-05	0.000458	CcSEcCtD
Acetaminophen—Insomnia—Dexamethasone—psoriasis	4.13e-05	0.000458	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.12e-05	0.000457	CcSEcCtD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.12e-05	0.00109	CbGpPWpGaD
Acetaminophen—Diarrhoea—Cyclosporine—psoriasis	4.12e-05	0.000457	CcSEcCtD
Acetaminophen—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	4.12e-05	0.00109	CbGpPWpGaD
Acetaminophen—Discomfort—Prednisone—psoriasis	4.1e-05	0.000455	CcSEcCtD
Acetaminophen—Mental disorder—Methotrexate—psoriasis	4.1e-05	0.000455	CcSEcCtD
Acetaminophen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.08e-05	0.00108	CbGpPWpGaD
Acetaminophen—Erythema—Methotrexate—psoriasis	4.08e-05	0.000452	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—psoriasis	4.08e-05	0.000452	CcSEcCtD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	4.05e-05	0.00107	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.04e-05	0.00107	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—psoriasis	4.04e-05	0.00107	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Prednisolone—psoriasis	4.04e-05	0.000448	CcSEcCtD
Acetaminophen—Dyspepsia—Dexamethasone—psoriasis	4.02e-05	0.000446	CcSEcCtD
Acetaminophen—Dyspepsia—Betamethasone—psoriasis	4.02e-05	0.000446	CcSEcCtD
Acetaminophen—Diarrhoea—Mycophenolate mofetil—psoriasis	4.02e-05	0.000446	CcSEcCtD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.01e-05	0.00106	CbGpPWpGaD
Acetaminophen—Urticaria—Triamcinolone—psoriasis	4e-05	0.000444	CcSEcCtD
Acetaminophen—Body temperature increased—Triamcinolone—psoriasis	3.98e-05	0.000442	CcSEcCtD
Acetaminophen—Dizziness—Cyclosporine—psoriasis	3.98e-05	0.000441	CcSEcCtD
Acetaminophen—Oedema—Prednisone—psoriasis	3.98e-05	0.000441	CcSEcCtD
Acetaminophen—Anaphylactic shock—Prednisone—psoriasis	3.98e-05	0.000441	CcSEcCtD
Acetaminophen—Decreased appetite—Betamethasone—psoriasis	3.97e-05	0.000441	CcSEcCtD
Acetaminophen—Decreased appetite—Dexamethasone—psoriasis	3.97e-05	0.000441	CcSEcCtD
Acetaminophen—PTGS2—Selenium Micronutrient Network—CRP—psoriasis	3.95e-05	0.00105	CbGpPWpGaD
Acetaminophen—Gastrointestinal disorder—Dexamethasone—psoriasis	3.95e-05	0.000438	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Betamethasone—psoriasis	3.95e-05	0.000438	CcSEcCtD
Acetaminophen—Hypersensitivity—Hydrocortisone—psoriasis	3.94e-05	0.000437	CcSEcCtD
Acetaminophen—Fatigue—Betamethasone—psoriasis	3.94e-05	0.000437	CcSEcCtD
Acetaminophen—Fatigue—Dexamethasone—psoriasis	3.94e-05	0.000437	CcSEcCtD
Acetaminophen—Shock—Prednisone—psoriasis	3.92e-05	0.000434	CcSEcCtD
Acetaminophen—Nervous system disorder—Prednisone—psoriasis	3.9e-05	0.000433	CcSEcCtD
Acetaminophen—Tachycardia—Prednisone—psoriasis	3.89e-05	0.000431	CcSEcCtD
Acetaminophen—Dizziness—Mycophenolate mofetil—psoriasis	3.88e-05	0.000431	CcSEcCtD
Acetaminophen—Skin disorder—Prednisone—psoriasis	3.87e-05	0.000429	CcSEcCtD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.86e-05	0.00102	CbGpPWpGaD
Acetaminophen—Hyperhidrosis—Prednisone—psoriasis	3.85e-05	0.000427	CcSEcCtD
Acetaminophen—Vision blurred—Methotrexate—psoriasis	3.84e-05	0.000426	CcSEcCtD
Acetaminophen—Asthenia—Hydrocortisone—psoriasis	3.84e-05	0.000426	CcSEcCtD
Acetaminophen—Vomiting—Cyclosporine—psoriasis	3.83e-05	0.000424	CcSEcCtD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.82e-05	0.00101	CbGpPWpGaD
Acetaminophen—Rash—Cyclosporine—psoriasis	3.8e-05	0.000421	CcSEcCtD
Acetaminophen—Anorexia—Prednisone—psoriasis	3.79e-05	0.000421	CcSEcCtD
Acetaminophen—Dermatitis—Cyclosporine—psoriasis	3.79e-05	0.000421	CcSEcCtD
Acetaminophen—Pruritus—Hydrocortisone—psoriasis	3.79e-05	0.00042	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—psoriasis	3.78e-05	0.000419	CcSEcCtD
Acetaminophen—Headache—Cyclosporine—psoriasis	3.77e-05	0.000418	CcSEcCtD
Acetaminophen—SULT2A1—Metabolism—CARM1—psoriasis	3.77e-05	0.000999	CbGpPWpGaD
Acetaminophen—Anaemia—Methotrexate—psoriasis	3.77e-05	0.000418	CcSEcCtD
Acetaminophen—Feeling abnormal—Betamethasone—psoriasis	3.77e-05	0.000418	CcSEcCtD
Acetaminophen—Feeling abnormal—Dexamethasone—psoriasis	3.77e-05	0.000418	CcSEcCtD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	3.75e-05	0.000995	CbGpPWpGaD
Acetaminophen—Gastrointestinal pain—Dexamethasone—psoriasis	3.74e-05	0.000414	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Betamethasone—psoriasis	3.74e-05	0.000414	CcSEcCtD
Acetaminophen—Vomiting—Mycophenolate mofetil—psoriasis	3.73e-05	0.000414	CcSEcCtD
Acetaminophen—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	3.73e-05	0.00099	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Triamcinolone—psoriasis	3.71e-05	0.000412	CcSEcCtD
Acetaminophen—Rash—Mycophenolate mofetil—psoriasis	3.7e-05	0.000411	CcSEcCtD
Acetaminophen—Dermatitis—Mycophenolate mofetil—psoriasis	3.7e-05	0.00041	CcSEcCtD
Acetaminophen—Headache—Mycophenolate mofetil—psoriasis	3.68e-05	0.000408	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—psoriasis	3.68e-05	0.000408	CcSEcCtD
Acetaminophen—Diarrhoea—Hydrocortisone—psoriasis	3.66e-05	0.000406	CcSEcCtD
Acetaminophen—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.65e-05	0.000968	CbGpPWpGaD
Acetaminophen—Leukopenia—Methotrexate—psoriasis	3.65e-05	0.000405	CcSEcCtD
Acetaminophen—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	3.63e-05	0.000963	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IL10—psoriasis	3.63e-05	0.000963	CbGpPWpGaD
Acetaminophen—Urticaria—Dexamethasone—psoriasis	3.63e-05	0.000403	CcSEcCtD
Acetaminophen—Urticaria—Betamethasone—psoriasis	3.63e-05	0.000403	CcSEcCtD
Acetaminophen—Dizziness—Prednisolone—psoriasis	3.62e-05	0.000402	CcSEcCtD
Acetaminophen—PTGS2—Spinal Cord Injury—IL4—psoriasis	3.62e-05	0.000958	CbGpPWpGaD
Acetaminophen—Asthenia—Triamcinolone—psoriasis	3.61e-05	0.000401	CcSEcCtD
Acetaminophen—Body temperature increased—Betamethasone—psoriasis	3.61e-05	0.000401	CcSEcCtD
Acetaminophen—Body temperature increased—Dexamethasone—psoriasis	3.61e-05	0.000401	CcSEcCtD
Acetaminophen—Abdominal pain—Betamethasone—psoriasis	3.61e-05	0.000401	CcSEcCtD
Acetaminophen—Abdominal pain—Dexamethasone—psoriasis	3.61e-05	0.000401	CcSEcCtD
Acetaminophen—Insomnia—Prednisone—psoriasis	3.6e-05	0.000399	CcSEcCtD
Acetaminophen—NAT2—Metabolism—CARM1—psoriasis	3.59e-05	0.000953	CbGpPWpGaD
Acetaminophen—Nausea—Cyclosporine—psoriasis	3.58e-05	0.000397	CcSEcCtD
Acetaminophen—Pruritus—Triamcinolone—psoriasis	3.56e-05	0.000395	CcSEcCtD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.56e-05	0.000944	CbGpPWpGaD
Acetaminophen—Cough—Methotrexate—psoriasis	3.56e-05	0.000394	CcSEcCtD
Acetaminophen—Dizziness—Hydrocortisone—psoriasis	3.54e-05	0.000392	CcSEcCtD
Acetaminophen—ABCB1—Allograft Rejection—IL4—psoriasis	3.53e-05	0.000936	CbGpPWpGaD
Acetaminophen—Convulsion—Methotrexate—psoriasis	3.53e-05	0.000392	CcSEcCtD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.52e-05	0.000934	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.51e-05	0.000929	CbGpPWpGaD
Acetaminophen—Dyspepsia—Prednisone—psoriasis	3.5e-05	0.000389	CcSEcCtD
Acetaminophen—Nausea—Mycophenolate mofetil—psoriasis	3.49e-05	0.000387	CcSEcCtD
Acetaminophen—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	3.48e-05	0.000923	CbGpPWpGaD
Acetaminophen—Chest pain—Methotrexate—psoriasis	3.47e-05	0.000385	CcSEcCtD
Acetaminophen—Decreased appetite—Prednisone—psoriasis	3.46e-05	0.000384	CcSEcCtD
Acetaminophen—ABCB1—Allograft Rejection—HLA-B—psoriasis	3.45e-05	0.000916	CbGpPWpGaD
Acetaminophen—Rash—Prednisolone—psoriasis	3.45e-05	0.000383	CcSEcCtD
Acetaminophen—Dermatitis—Prednisolone—psoriasis	3.45e-05	0.000383	CcSEcCtD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	3.45e-05	0.000915	CbGpPWpGaD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.45e-05	0.000382	CcSEcCtD
Acetaminophen—Fatigue—Prednisone—psoriasis	3.43e-05	0.000381	CcSEcCtD
Acetaminophen—Headache—Prednisolone—psoriasis	3.43e-05	0.000381	CcSEcCtD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.43e-05	0.000909	CbGpPWpGaD
Acetaminophen—Discomfort—Methotrexate—psoriasis	3.43e-05	0.00038	CcSEcCtD
Acetaminophen—Constipation—Prednisone—psoriasis	3.4e-05	0.000377	CcSEcCtD
Acetaminophen—Vomiting—Hydrocortisone—psoriasis	3.4e-05	0.000377	CcSEcCtD
Acetaminophen—UGT2B15—Metabolism—CARM1—psoriasis	3.38e-05	0.000896	CbGpPWpGaD
Acetaminophen—Rash—Hydrocortisone—psoriasis	3.37e-05	0.000374	CcSEcCtD
Acetaminophen—Dermatitis—Hydrocortisone—psoriasis	3.37e-05	0.000374	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—psoriasis	3.35e-05	0.000372	CcSEcCtD
Acetaminophen—Headache—Hydrocortisone—psoriasis	3.35e-05	0.000372	CcSEcCtD
Acetaminophen—Dizziness—Triamcinolone—psoriasis	3.33e-05	0.000369	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—psoriasis	3.33e-05	0.000369	CcSEcCtD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	3.3e-05	0.000874	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Prednisone—psoriasis	3.28e-05	0.000364	CcSEcCtD
Acetaminophen—Asthenia—Betamethasone—psoriasis	3.28e-05	0.000364	CcSEcCtD
Acetaminophen—Asthenia—Dexamethasone—psoriasis	3.28e-05	0.000364	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—psoriasis	3.26e-05	0.000362	CcSEcCtD
Acetaminophen—CNR1—Signaling Pathways—CCL20—psoriasis	3.26e-05	0.000865	CbGpPWpGaD
Acetaminophen—Thrombocytopenia—Methotrexate—psoriasis	3.26e-05	0.000361	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Prednisone—psoriasis	3.26e-05	0.000361	CcSEcCtD
Acetaminophen—Nausea—Prednisolone—psoriasis	3.25e-05	0.000361	CcSEcCtD
Acetaminophen—Pruritus—Dexamethasone—psoriasis	3.23e-05	0.000359	CcSEcCtD
Acetaminophen—Pruritus—Betamethasone—psoriasis	3.23e-05	0.000359	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—psoriasis	3.23e-05	0.000358	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—psoriasis	3.22e-05	0.000357	CcSEcCtD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.22e-05	0.000852	CbGpPWpGaD
Acetaminophen—Vomiting—Triamcinolone—psoriasis	3.2e-05	0.000355	CcSEcCtD
Acetaminophen—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.2e-05	0.000848	CbGpPWpGaD
Acetaminophen—Nausea—Hydrocortisone—psoriasis	3.18e-05	0.000352	CcSEcCtD
Acetaminophen—Rash—Triamcinolone—psoriasis	3.18e-05	0.000352	CcSEcCtD
Acetaminophen—Dermatitis—Triamcinolone—psoriasis	3.17e-05	0.000352	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—psoriasis	3.17e-05	0.000352	CcSEcCtD
Acetaminophen—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.16e-05	0.000838	CbGpPWpGaD
Acetaminophen—Urticaria—Prednisone—psoriasis	3.16e-05	0.000351	CcSEcCtD
Acetaminophen—Headache—Triamcinolone—psoriasis	3.16e-05	0.00035	CcSEcCtD
Acetaminophen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.15e-05	0.000834	CbGpPWpGaD
Acetaminophen—Abdominal pain—Prednisone—psoriasis	3.15e-05	0.000349	CcSEcCtD
Acetaminophen—Body temperature increased—Prednisone—psoriasis	3.15e-05	0.000349	CcSEcCtD
Acetaminophen—Diarrhoea—Betamethasone—psoriasis	3.13e-05	0.000347	CcSEcCtD
Acetaminophen—Diarrhoea—Dexamethasone—psoriasis	3.13e-05	0.000347	CcSEcCtD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.11e-05	0.000825	CbGpPWpGaD
Acetaminophen—Hypotension—Methotrexate—psoriasis	3.11e-05	0.000345	CcSEcCtD
Acetaminophen—SULT1E1—Metabolism—CAT—psoriasis	3.06e-05	0.000811	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—LEP—psoriasis	3.06e-05	0.000811	CbGpPWpGaD
Acetaminophen—Dizziness—Dexamethasone—psoriasis	3.02e-05	0.000335	CcSEcCtD
Acetaminophen—Dizziness—Betamethasone—psoriasis	3.02e-05	0.000335	CcSEcCtD
Acetaminophen—UGT1A1—Metabolism—NDUFA5—psoriasis	3.01e-05	0.000798	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—NDUFA5—psoriasis	3.01e-05	0.000798	CbGpPWpGaD
Acetaminophen—Insomnia—Methotrexate—psoriasis	3.01e-05	0.000334	CcSEcCtD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.01e-05	0.000797	CbGpPWpGaD
Acetaminophen—Nausea—Triamcinolone—psoriasis	2.99e-05	0.000332	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—psoriasis	2.97e-05	0.000329	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—psoriasis	2.96e-05	0.000328	CcSEcCtD
Acetaminophen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.94e-05	0.000778	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Prednisone—psoriasis	2.93e-05	0.000325	CcSEcCtD
Acetaminophen—Dyspepsia—Methotrexate—psoriasis	2.93e-05	0.000325	CcSEcCtD
Acetaminophen—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.92e-05	0.000775	CbGpPWpGaD
Acetaminophen—Vomiting—Betamethasone—psoriasis	2.91e-05	0.000322	CcSEcCtD
Acetaminophen—Vomiting—Dexamethasone—psoriasis	2.91e-05	0.000322	CcSEcCtD
Acetaminophen—CNR1—GPCR ligand binding—CXCL8—psoriasis	2.91e-05	0.00077	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	2.9e-05	0.000768	CbGpPWpGaD
Acetaminophen—Decreased appetite—Methotrexate—psoriasis	2.89e-05	0.000321	CcSEcCtD
Acetaminophen—Rash—Dexamethasone—psoriasis	2.88e-05	0.00032	CcSEcCtD
Acetaminophen—Rash—Betamethasone—psoriasis	2.88e-05	0.00032	CcSEcCtD
Acetaminophen—Dermatitis—Dexamethasone—psoriasis	2.88e-05	0.000319	CcSEcCtD
Acetaminophen—Dermatitis—Betamethasone—psoriasis	2.88e-05	0.000319	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—psoriasis	2.87e-05	0.000318	CcSEcCtD
Acetaminophen—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	2.87e-05	0.000761	CbGpPWpGaD
Acetaminophen—Fatigue—Methotrexate—psoriasis	2.87e-05	0.000318	CcSEcCtD
Acetaminophen—Headache—Betamethasone—psoriasis	2.86e-05	0.000318	CcSEcCtD
Acetaminophen—Headache—Dexamethasone—psoriasis	2.86e-05	0.000318	CcSEcCtD
Acetaminophen—Asthenia—Prednisone—psoriasis	2.86e-05	0.000317	CcSEcCtD
Acetaminophen—PTGS2—Spinal Cord Injury—NOS2—psoriasis	2.85e-05	0.000755	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—CARM1—psoriasis	2.82e-05	0.000748	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	2.82e-05	0.000747	CbGpPWpGaD
Acetaminophen—Pruritus—Prednisone—psoriasis	2.82e-05	0.000312	CcSEcCtD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	2.81e-05	0.000745	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.81e-05	0.000744	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—CD4—psoriasis	2.77e-05	0.000734	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	2.76e-05	0.000732	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Methotrexate—psoriasis	2.74e-05	0.000304	CcSEcCtD
Acetaminophen—Diarrhoea—Prednisone—psoriasis	2.72e-05	0.000302	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—psoriasis	2.72e-05	0.000302	CcSEcCtD
Acetaminophen—Nausea—Betamethasone—psoriasis	2.72e-05	0.000301	CcSEcCtD
Acetaminophen—Nausea—Dexamethasone—psoriasis	2.72e-05	0.000301	CcSEcCtD
Acetaminophen—SULT1A1—Metabolism—CAT—psoriasis	2.69e-05	0.000714	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	2.69e-05	0.000713	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.67e-05	0.000707	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.67e-05	0.000707	CbGpPWpGaD
Acetaminophen—Urticaria—Methotrexate—psoriasis	2.64e-05	0.000293	CcSEcCtD
Acetaminophen—Dizziness—Prednisone—psoriasis	2.63e-05	0.000292	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—psoriasis	2.63e-05	0.000292	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—psoriasis	2.63e-05	0.000292	CcSEcCtD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.63e-05	0.000697	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CYP2S1—psoriasis	2.56e-05	0.000679	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CYP2S1—psoriasis	2.56e-05	0.000679	CbGpPWpGaD
Acetaminophen—Vomiting—Prednisone—psoriasis	2.53e-05	0.000281	CcSEcCtD
Acetaminophen—Rash—Prednisone—psoriasis	2.51e-05	0.000278	CcSEcCtD
Acetaminophen—Dermatitis—Prednisone—psoriasis	2.51e-05	0.000278	CcSEcCtD
Acetaminophen—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	2.5e-05	0.000663	CbGpPWpGaD
Acetaminophen—Headache—Prednisone—psoriasis	2.49e-05	0.000277	CcSEcCtD
Acetaminophen—PTGS1—Metabolism—NDUFA5—psoriasis	2.46e-05	0.000651	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Methotrexate—psoriasis	2.45e-05	0.000272	CcSEcCtD
Acetaminophen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	2.45e-05	0.000649	CbGpPWpGaD
Acetaminophen—Asthenia—Methotrexate—psoriasis	2.39e-05	0.000265	CcSEcCtD
Acetaminophen—SULT1E1—Metabolism—APOE—psoriasis	2.38e-05	0.00063	CbGpPWpGaD
Acetaminophen—Nausea—Prednisone—psoriasis	2.36e-05	0.000262	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—psoriasis	2.35e-05	0.000261	CcSEcCtD
Acetaminophen—CYP2A6—Metabolism—NDUFA5—psoriasis	2.32e-05	0.000615	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—CAT—psoriasis	2.32e-05	0.000614	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.31e-05	0.000612	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	2.3e-05	0.00061	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.29e-05	0.000607	CbGpPWpGaD
Acetaminophen—Diarrhoea—Methotrexate—psoriasis	2.28e-05	0.000252	CcSEcCtD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.27e-05	0.000602	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	2.25e-05	0.000597	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—CAT—psoriasis	2.21e-05	0.000586	CbGpPWpGaD
Acetaminophen—Dizziness—Methotrexate—psoriasis	2.2e-05	0.000244	CcSEcCtD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.19e-05	0.00058	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IFNG—psoriasis	2.19e-05	0.000579	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IFNG—psoriasis	2.14e-05	0.000566	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.13e-05	0.000565	CbGpPWpGaD
Acetaminophen—Vomiting—Methotrexate—psoriasis	2.12e-05	0.000235	CcSEcCtD
Acetaminophen—Rash—Methotrexate—psoriasis	2.1e-05	0.000233	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—psoriasis	2.1e-05	0.000232	CcSEcCtD
Acetaminophen—SULT1A1—Metabolism—APOE—psoriasis	2.09e-05	0.000554	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000553	CbGpPWpGaD
Acetaminophen—Headache—Methotrexate—psoriasis	2.08e-05	0.000231	CcSEcCtD
Acetaminophen—UGT2B15—Metabolism—CAT—psoriasis	2.08e-05	0.000551	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PPARG—psoriasis	2.07e-05	0.000549	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	2.03e-05	0.000539	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.99e-05	0.000526	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.98e-05	0.000526	CbGpPWpGaD
Acetaminophen—Nausea—Methotrexate—psoriasis	1.98e-05	0.000219	CcSEcCtD
Acetaminophen—CYP2A6—Metabolism—CYP2S1—psoriasis	1.97e-05	0.000523	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—NDUFA5—psoriasis	1.95e-05	0.000517	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.94e-05	0.000514	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.86e-05	0.000494	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—NDUFA5—psoriasis	1.83e-05	0.000486	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PPARG—psoriasis	1.82e-05	0.000483	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	1.82e-05	0.000482	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.82e-05	0.000482	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—APOE—psoriasis	1.8e-05	0.000477	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SOCS1—psoriasis	1.8e-05	0.000476	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	1.79e-05	0.000474	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—CAT—psoriasis	1.73e-05	0.00046	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—NDUFA5—psoriasis	1.73e-05	0.000459	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—APOE—psoriasis	1.72e-05	0.000455	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—TYK2—psoriasis	1.71e-05	0.000454	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.7e-05	0.000451	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.7e-05	0.000451	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	1.69e-05	0.000447	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CYP2S1—psoriasis	1.66e-05	0.000439	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CXCL8—psoriasis	1.64e-05	0.000435	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.64e-05	0.000433	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—APOE—psoriasis	1.62e-05	0.000428	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.61e-05	0.000428	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.61e-05	0.000427	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—NDUFA5—psoriasis	1.59e-05	0.00042	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PPARG—psoriasis	1.57e-05	0.000416	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CYP2S1—psoriasis	1.56e-05	0.000414	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PPARG—psoriasis	1.5e-05	0.000397	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CXCL8—psoriasis	1.49e-05	0.000395	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.48e-05	0.000392	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CYP2S1—psoriasis	1.47e-05	0.00039	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	1.44e-05	0.000383	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TNF—psoriasis	1.41e-05	0.000375	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PPARG—psoriasis	1.41e-05	0.000373	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—TNF—psoriasis	1.38e-05	0.000366	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NDUFA5—psoriasis	1.38e-05	0.000366	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.37e-05	0.000364	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CYP2S1—psoriasis	1.35e-05	0.000357	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—APOE—psoriasis	1.35e-05	0.000357	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.34e-05	0.000356	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—LEP—psoriasis	1.33e-05	0.000351	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—APOE—psoriasis	1.33e-05	0.000351	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NDUFA5—psoriasis	1.3e-05	0.000345	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NDUFA5—psoriasis	1.29e-05	0.000342	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.29e-05	0.000341	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.28e-05	0.00034	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CARM1—psoriasis	1.25e-05	0.000332	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CARM1—psoriasis	1.25e-05	0.000332	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—psoriasis	1.25e-05	0.000331	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.24e-05	0.000328	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NFKBIA—psoriasis	1.24e-05	0.000327	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.23e-05	0.000325	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.2e-05	0.000319	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CYP2S1—psoriasis	1.17e-05	0.000311	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PPARG—psoriasis	1.17e-05	0.000311	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.17e-05	0.00031	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IL6—psoriasis	1.14e-05	0.000303	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.12e-05	0.000298	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CYP2S1—psoriasis	1.11e-05	0.000293	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NDUFA5—psoriasis	1.1e-05	0.000292	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CYP2S1—psoriasis	1.1e-05	0.000291	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.09e-05	0.00029	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.03e-05	0.000273	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CARM1—psoriasis	1.02e-05	0.00027	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TYK2—psoriasis	1.01e-05	0.000268	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CARM1—psoriasis	9.64e-06	0.000256	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.62e-06	0.000255	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.53e-06	0.000253	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP2S1—psoriasis	9.38e-06	0.000249	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.11e-06	0.000241	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CXCL8—psoriasis	8.81e-06	0.000234	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	8.77e-06	0.000232	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.69e-06	0.00023	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NDUFA5—psoriasis	8.51e-06	0.000226	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.48e-06	0.000225	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—IL6—psoriasis	8.38e-06	0.000222	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—JUN—psoriasis	8.19e-06	0.000217	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CARM1—psoriasis	8.09e-06	0.000215	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	7.96e-06	0.000211	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NFKB1—psoriasis	7.88e-06	0.000209	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.71e-06	0.000204	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CAT—psoriasis	7.69e-06	0.000204	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CAT—psoriasis	7.69e-06	0.000204	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CARM1—psoriasis	7.62e-06	0.000202	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.57e-06	0.000201	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP2S1—psoriasis	7.24e-06	0.000192	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CARM1—psoriasis	7.18e-06	0.00019	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—VEGFA—psoriasis	7.15e-06	0.00019	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—STAT3—psoriasis	7.08e-06	0.000188	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.07e-06	0.000187	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	6.82e-06	0.000181	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.71e-06	0.000178	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CARM1—psoriasis	6.59e-06	0.000175	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CAT—psoriasis	6.27e-06	0.000166	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.16e-06	0.000163	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.01e-06	0.000159	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—APOE—psoriasis	5.98e-06	0.000158	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—APOE—psoriasis	5.98e-06	0.000158	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CAT—psoriasis	5.93e-06	0.000157	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.75e-06	0.000152	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CARM1—psoriasis	5.74e-06	0.000152	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CARM1—psoriasis	5.41e-06	0.000143	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—psoriasis	5.41e-06	0.000143	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CARM1—psoriasis	5.36e-06	0.000142	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PPARG—psoriasis	5.21e-06	0.000138	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PPARG—psoriasis	5.21e-06	0.000138	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.01e-06	0.000133	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CAT—psoriasis	4.98e-06	0.000132	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL6—psoriasis	4.95e-06	0.000131	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HLA-A—psoriasis	4.95e-06	0.000131	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.92e-06	0.00013	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—APOE—psoriasis	4.87e-06	0.000129	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CAT—psoriasis	4.69e-06	0.000124	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APOE—psoriasis	4.62e-06	0.000122	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—APOE—psoriasis	4.61e-06	0.000122	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CARM1—psoriasis	4.58e-06	0.000121	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CAT—psoriasis	4.42e-06	0.000117	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NOS2—psoriasis	4.3e-06	0.000114	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.28e-06	0.000113	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPARG—psoriasis	4.24e-06	0.000113	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CAT—psoriasis	4.05e-06	0.000107	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPARG—psoriasis	4.01e-06	0.000106	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—APOE—psoriasis	3.87e-06	0.000103	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—APOE—psoriasis	3.64e-06	9.65e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CARM1—psoriasis	3.54e-06	9.37e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CAT—psoriasis	3.53e-06	9.35e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TYK2—psoriasis	3.53e-06	9.34e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—APOE—psoriasis	3.43e-06	9.1e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPARG—psoriasis	3.37e-06	8.93e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CAT—psoriasis	3.33e-06	8.82e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CAT—psoriasis	3.3e-06	8.74e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CD4—psoriasis	3.19e-06	8.45e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPARG—psoriasis	3.17e-06	8.41e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—APOE—psoriasis	3.15e-06	8.34e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPARG—psoriasis	2.99e-06	7.93e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CAT—psoriasis	2.82e-06	7.47e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—APOE—psoriasis	2.74e-06	7.27e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPARG—psoriasis	2.74e-06	7.27e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—APOE—psoriasis	2.58e-06	6.85e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—APOE—psoriasis	2.56e-06	6.79e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—STAT3—psoriasis	2.47e-06	6.54e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPARG—psoriasis	2.39e-06	6.33e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPARG—psoriasis	2.25e-06	5.97e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPARG—psoriasis	2.23e-06	5.91e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—APOE—psoriasis	2.19e-06	5.8e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CAT—psoriasis	2.17e-06	5.76e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPARG—psoriasis	1.91e-06	5.05e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—IL6—psoriasis	1.72e-06	4.57e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—APOE—psoriasis	1.69e-06	4.48e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPARG—psoriasis	1.47e-06	3.9e-05	CbGpPWpGaD
